Navigation Links
PhRMA Statement Supporting Fair Incentives for Biologics Innovation
Date:10/19/2009

WASHINGTON, Oct. 19 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding appropriate incentives for continued biotechnology innovation:

"PhRMA, along with research universities, patients, healthcare providers, and elected leaders at the state and federal levels, supports the development of a responsible, abbreviated approval pathway for biosimilars that includes a fair period of data protection that is critical for the future of medical progress.

"Legislation moving forward in the U.S. House and Senate provides for patient safety and strikes the appropriate balance between the desire for enhanced competition for biologics, and the need to provide meaningful incentives for innovation.

"Such incentives are vital for ensuring continued development of new biologics that are needed to provide future treatments and cures for such serious ailments as Alzheimer's disease, Parkinson's and cancer. Already, biologic medicines have revolutionized patient care. In fact, these cutting-edge therapies are among the reasons why American patients with life-threatening diseases, like cancer, are living longer.

"The pathway endorsed through strong bipartisan Congressional votes would allow onto the market biosimilars -- medicines that are similar to, but will never be exactly the same as, the original biologic.

"That key element -- similarity -- factors into investment decisions, because the nature of patent protection for biologics is uncertain in the context of biosimilars. Because biologics are extremely complex, patents may cover just part of the molecule or simply cover the process for its manufacture.

"In the future, should this legislation become law, a biosimilar manufacturer using its own manufacturing process to create a biosimilar that differs slightly from an innovator biologic would
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. PhRMA Statement on Senate Finance Committee Vote
2. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
3. SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
4. EAU Position Statement on Screening for Prostate Cancer
5. Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients
6. A Joint Statement From Americas Prostate Cancer Advocacy, Education, and Support Organizations
7. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
8. American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression
9. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
10. VA Statement on Smoking Cessation Research Program
11. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... The U.S. Food and Drug Administration (FDA) approved ... for the treatment of schizophrenia in adults, Eli ... announced today. ZYPREXA RELPREVV, a long-acting intramuscular injection, ... four weeks. ,, Different from both oral and ... for stable concentrations of the active drug to ...
(Date:12/14/2009)... 14 Pf enex Inc. ... Inc., through an affiliate, an exclusive worldwide license to ... protein expression technology for the production of specific proteins ... an undisclosed vaccine candidate. ,, Under the terms ... receive approximately $52 million in upfront and milestone payments ...
(Date:12/14/2009)... 14 CPG International, Inc., manufacturer ... products, introduces VYCOM, a rebranded business unit. ... VYCOM Corporation and Scranton Products Industrial business ... business unit within CPG International, Inc. alongside ... The VYCOM business unit has new, redefined ...
Breaking Medicine Technology:FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8Extended Antiviral May Benefit Kidney Transplant Patients 57599 1U S Chamber 3A Medical Liability Reform Must Have Teeth to be Effective 57594 1HHS Prevention and Wellness Initiative Including Tobacco Control Is Smart Investment in Americas Health 57589 1HHS Prevention and Wellness Initiative Including Tobacco Control Is Smart Investment in Americas Health 57589 2HHS Prevention and Wellness Initiative Including Tobacco Control Is Smart Investment in Americas Health 57589 3
(Date:12/15/2009)... UT Southwestern Medical Center researchers have provided ... unique observable characteristics seen in patients with an ... reported online and in the December issue of ... suggest that patients with atypical progeroid syndrome ... diagnosed with two similar but more well-defined accelerated ...
(Date:12/14/2009)... new liposuction and fat transfer treatments can help people slim ... minimally invasive treatment. , ... (PRWEB) ... can remove excess fat from the abdomen and inject it ... reduce facial wrinkling and enhance lips all in one safe, ...
(Date:12/14/2009)... -- Heska Corporation (Nasdaq: HSKA ; ... of veterinary diagnostic and specialty products, today ... Company,s new DRI-CHEM® 7000 Veterinary Chemistry Analyzer ... ) ,, Customers receiving these analyzers have ... analyzer available to the veterinary in-clinic market. ...
(Date:12/14/2009)... United Dental Care (also known as Culver City ... dental care in Southern California. We provide treatments in ... (orthodontics) and periodontal treatments. Beverly Hills Dentist ... staffed with experienced and trusted dentists who provide these ... E) is one of these trusted dentists. He is ...
(Date:12/14/2009)... Kurisko practiced in Canada for 13 years under government controlled health ... a free-market economy. In speaking engagements and in his new book, ... of the fragility of such a system and its threat to ... ... -- Lee Kurisko , a diagnostic radiologist from Minnesota, warns ...
Breaking Medicine News(10 mins):Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:United Dental Care, Gentle Care, Trusted Dentists 2Health News:United Dental Care, Gentle Care, Trusted Dentists 3Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2
... revealed that there has been an increase in heart failure cases ... // with men surviving for longer periods. There has been ... 1990 to 1994 period when compared to the 1970 to 1974 ... to the study. ,The chances of heart failure ...
... Pharmaceuticals, has been approved by the European authorities to ... children’s between the ages of 1 to 12 years. ... situated in Switzerland and are manufacturers of Tamiflu drug. ... effective influenza virus drug, which inhibits the replication of ...
... particularly in South Asia to prohibit smoking among the members ... British Medical Journal (BMJ). The help of the Muslim clergy ... ,The researchers analyzed data on the prevalence of smoking in ... rates in each of these countries is significantly higher among ...
... from eating disorders do not reveal it to anyone for a ... As many as 1,000 youngsters were studied, and the // parents ... such disorders in their children, while only 21% of the children ... ,The research was conducted by the Eating Disorders Association (EDA) which ...
... charges cost so dear, that cancer patients, ill afford ... Charity Breast Cancer Care, 42% of breast cancer patients, ... financial incapacity to afford the prescription charges. Out of ... 15% said they were forced to discontinue the treatment ...
... there could be a common gene which gives rise to ... University School of Medicine. This could also serve to conclusively ... sought from about 1,000 families in which the Alzheimer's disease ... ,The genetic link with regard to the disease was sought ...
Other Medicine News:Health News:Eating Disorders Among Children Are Widespread 2
... CoreTherm Microwave Thermotherapy System is the ... treatment of symptomatic BPH. Other thermotherapy ... protocols, discounting the effect of each ... will have on achieving the desired ...
... the release of the OES Pro line of ... most commonly used cystoscopy sheaths has taken Olympus ... can have one instrument that performs it all. ... cystoscopes offer a superior channel size while maintaining ...
... Whether you need ... office or at a ... complete mobility,for the healthcare ... Its,user-friendly touchscreen allows easy,navigation, ...
Fast, accurate SpO2 measurements always within reach....
Medicine Products: